Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PACIRA BIOSCIENCES, INC.

(PCRX)
  Report
Real-time Estimate Cboe BZX  -  12:37:28 2023-02-02 pm EST
41.77 USD   +2.95%
01/31Wedbush Assumes Pacira BioSciences at Outperform, Cuts Price Target to $60 From $88
MT
01/09Transcript : Pacira BioSciences, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 03:00 PM
CI
01/06Needham Adjusts Price Target on Pacira BioSciences to $63 From $66, Maintains Buy Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on PACIRA BIOSCIENCES, INC.
01/31Wedbush Assumes Pacira BioSciences at Outperform, Cuts Price Target to $60 From $88
MT
01/06Needham Adjusts Price Target on Pacira BioSciences to $63 From $66, Maintains Buy Ratin..
MT
01/06BMO Capital Adjusts Price Target on Pacira BioSciences to $52 From $60, Maintains Marke..
MT
2022BMO Capital Adjusts Price Target on Pacira BioSciences to $60 From $66, Maintains Marke..
MT
2022HC Wainwright Adjusts Price Target on Pacira BioSciences to $76 From $83, Maintains Buy..
MT
2022RBC Trims Pacira BioSciences' Price Target to $80 From $82, Keeps Outperform Rating
MT
2022Wedbush Lowers Pacira BioSciences' Price Target to $88 From $94, Keeps Outperform Ratin..
MT
2022Jefferies Assumes Pacira BioSciences at Buy with $66 Price Target
MT
2022RBC Raises Price Target on Pacira BioSciences to $82 From $81, Maintains Outperform Rat..
MT
2022RBC Cuts Price Target on Pacira BioSciences to $81 From $83, Maintains Outperform Ratin..
MT
2022Piper Sandler Adjusts Price Target on Pacira BioSciences to $80 From $84, Reiterates Ov..
MT
2022RBC Raises Price Target on Pacira BioSciences to $83 From $81, Maintains Outperform Rat..
MT
2022Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcar..
MT
2022Needham Adjusts Price Target on Pacira BioSciences to $76 From $84, Reiterates Buy Rati..
MT
2022RBC Capital Adjusts Pacira BioSciences' Price Target to $81 From $85, Maintains Outperf..
MT
2022RBC Capital Adjusts Pacira BioSciences' Price Target to $85 From $83, Maintains Outperf..
MT
2022Northland Securities Adjusts Pacira BioSciences Price Target to $67 From $61, Maintains..
MT
2022Wedbush Trims Pacira BioSciences' Price Target to $94 From $97 on Zilretta 2022 Revenue..
MT
2022HC Wainwright Adjusts Pacira BioSciences Price Target to $90 From $86, Maintains Buy Ra..
MT
2022Barclays Adjusts Pacira BioSciences Price Target to $96 From $92, Maintains Overweight ..
MT
2022RBC Cuts Price Target on Pacira BioSciences to $83 From $86, Maintains Outperform Ratin..
MT
2022JPMorgan Reinstates Pacira BioSciences at Overweight With $83 Price Target
MT
2021Wedbush Lifts Pacira BioSciences' Price Target to $97 From $93, Citing Zilretta Revenue..
MT
2021Berenberg Bank Adjusts Pacira BioSciences PT to $89 From $93, Maintains Buy Rating
MT
2021HC Wainwright Adjusts Pacira BioSciences PT to $86 From $80, Maintains Buy Rating
MT
2021Pacira BioSciences : Needham Adjusts Pacira BioSciences' Price Target..
MT
2021Pacira BioSciences : BMO Capital Lowers Pacira BioSciences' PT to $60..
MT
2021Pacira BioSciences : HC Wainwright Adjusts Pacira BioSciences' PT to ..
MT
2021Pacira BioSciences : Northland Securities Adjusts Pacira BioSciences ..
MT
2021Pacira BioSciences : Barclays Adjusts Price Target on Pacira BioScien..
MT
2021Pacira BioSciences : HC Wainwright Adjusts Price Target on Pacira Bio..
MT
2021Pacira BioSciences : JPMorgan Upgrades Pacira BioSciences to Overweig..
MT
2021Pacira BioSciences : BMO Capital Adjusts Pacira BioSciences PT to $70..
MT
2021Pacira BioSciences : Northland Capital Adjusts Pacira BioSciences PT ..
MT
2021Pacira BioSciences : Berenberg Initiates Pacira BioSciences at Buy Ra..
MT
2021Pacira BioSciences : Wedbush Raises Pacira BioSciences' PT to $93 fro..
MT
2021Pacira BioSciences : HC Wainwright & Co. Adjusts Price Target on Paci..
MT
2021Pacira BioSciences : Barclays Adjusts Price Target on Pacira BioScien..
MT
2021Pacira BioSciences : RBC Capital Adjusts Price Target on Pacira BioSc..
MT
2021Pacira BioSciences : Wedbush Adjusts Price Target on Pacira BioScienc..
MT
2021Pacira BioSciences : Northland Downgrades Pacira BioSciences to Marke..
MT
2021Pacira BioSciences : SVB Leerink Downgrades Pacira BioSciences to Mar..
MT
2021Pacira BioSciences : Needham Adjusts Price Target on Pacira BioScienc..
MT
2021Pacira BioSciences : RBC Capital Adjusts Pacira BioSciences' Price Ta..
MT
2020Pacira BioSciences : Needham Adjusts Price Target on Pacira BioScienc..
MT
2020Pacira BioSciences : Wedbush Adjusts Pacira BioSciences' Price Target..
MT
Upcoming event on PACIRA BIOSCIENCES, INC.